Setsuo Hirohashi

Title: The Innovative Contributions of Setsuo Hirohashi

Introduction

Setsuo Hirohashi is a notable inventor based in Tokyo, Japan. He is recognized for his significant contributions to the field of cancer research, particularly through his innovative work on monoclonal antibodies. His research has the potential to impact cancer diagnostics and treatment.

Latest Patents

Hirohashi holds a patent for a monoclonal antibody to human cancer antigen and the method for producing it. This invention discloses a monoclonal antibody of the IgM class that reacts with a glycoprotein antigen having a molecular weight of 1,000,000 or higher. The antibody recognizes a sugar chain with a sialic acid residue at the end. The characteristics of this monoclonal antibody include reactivity with various human cancers, such as those of the stomach, large intestine, pancreas, breast, lung, biliary duct, uterus, and esophagus. Additionally, it shows reactivity with normal human tissues, including the submaxillary gland and liver cell membrane, while remaining non-reactive with the normal human prostate gland and pancreatic duct. The method for producing these monoclonal antibodies involves administering cancer cells to an animal without a thymus, propagating the cells, and fusing B cells with myeloma cells to create antibody-producing cells.

Career Highlights

Throughout his career, Setsuo Hirohashi has made significant strides in the field of immunology and cancer research. His work has led to advancements in understanding how monoclonal antibodies can be utilized in the fight against cancer. He has been associated with reputable organizations, including Nippon Kayaku Kabushiki Kaisha, where he has furthered his research and development efforts.

Collaborations

Hirohashi has collaborated with esteemed colleagues such as Yukio Shimosato and Masahiko Watanabe. These collaborations have contributed to the advancement of knowledge in the field of cancer research and the development of innovative therapeutic approaches.

Conclusion

Setsuo Hirohashi's contributions to the field of cancer research through his innovative patent on monoclonal antibodies highlight his role as a significant inventor. His work continues to inspire advancements in cancer diagnostics and treatment methodologies.